Ticker: RGBP

Regen Biopharma, Inc. (OTCBB: RGBP) - Quick read on what's happening inside Regen Biopharma is a micro‑cap regenerative medicine/licensing company with heavy related‑party activity, persistent losses, and volatile non‑cash derivative charges that drive most of the year‑to‑date deterioration. Mana...

Company Overview: Regen Biopharma, Inc. (OTCBB: RGBP) is focused on the development of regenerative medical applications, primarily through licensing agreements. Latest Developments: Revenues for Q2 2025 were stable, showing minor fluctuations compared to the same period in 2024, with total reve...

Regen Biopharma, Inc. (OTCBB: RGBP) - Q1 2024 Financial Overview Regen Biopharma, Inc., a company focused on developing regenerative medical applications, recently reported its financial performance for the quarter ended December 31, 2024. The highlights reveal both challenges and slight operatio...